Bio-Rad

Sponsored • 16.09.2025 • Whitepaper • Bioprocessing

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Download this complimentary Expert Insights eBook today!

08.07.2025 • News

Bio-Rad Acquires Stilla Technologies

Bio-Rad Laboratories, a life science research and clinical diagnostics company, has completed the acquisition of Stilla Technologies, a developer of digital PCR (dPCR) systems.

Top-Feature

MOC – Event Center Messe München

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Free Expert Insights

Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Bio-Rad Laboratories

Bio-Rad

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Bio-Rad Acquires Stilla Technologies

Top-Feature

A successful concept on course for expansion — maintenance Munich 2025

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Advanced Recycling Conference 2025: New Paths to the Circular Economy

20 Years of CHEManager International

Brenntag Downsizes Management Board, Retains Both Divisions

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Free Expert Insights

Dual‑Targeting Breakthroughs

Newsletter & e-edition